2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$85.37+$0.005 (+0.006%)
Price as of Oct 02, 2026 7:53 PM EDT- $32.5BMarket Cap
- 27.31%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$85.37+$0.005 (+0.006%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $85.36 | ||
Change | -$0.87 (-1.01%) | ||
Open | $86.67 | ||
High | $86.67 | ||
Low | $84.80 | ||
Previous Close | $86.23 | ||
Volume | 2,230,090 | ||
30-Day Average Volume | 3,990,537 | ||
1-Week Change | -1.45% | ||
1-Month Change | -4.83% | ||
1-Year Change | 27.31% | ||
3-Year Change | -9.72% | ||
5-Year Change | -37.91% | ||
Fundamentals | |||
Shares Outstanding | 377.4M | ||
Total Assets | $6.5B | ||
Market Cap | $32.5B | ||
Enterprise Value | $32.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $249.1M | ||
Free Cash Flow | $184.5M | ||
EBIT | $319.7M | ||
EBITDA | $387.9M | ||
Net Working Capital | $1.7B | ||
EPS | $0.64 | ||
Enterprise Value/EBITDA | 84 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 12 | ||
P/E | 135 | ||
PEG | 5 | ||
Price/Free Cash Flow | 176 | ||
Price/Operating Cash Flow | 121 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue